OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.
about
Recent advances in migraine therapyEffects of OnabotulintoxinA on Habituation of Laser Evoked Responses in Chronic MigraineIncreased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.Onabotulinumtoxin-A treatment in Greek patients with chronic migraineOnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study.Botulinum toxin in the management of chronic migraine: clinical evidence and experience.Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting.Chronic migraine treatment: from OnabotulinumtoxinA onwards.Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline dataOnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience.Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy.Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life.OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study.Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine.OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.A Critical Evaluation on MOH Current Treatments.OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
P2860
Q26743537-89A38A42-AE4E-4032-A99D-6AD05A29232FQ36032213-5949B6A6-F880-484D-B0DC-B7A5C0E95F45Q36869674-7104FFFC-C0CB-4FEC-AFF0-1AFF4E0D3F81Q37263045-E6ADE6CD-B041-4755-AEF3-E18983F48751Q37650532-BC210693-A8D2-4E27-B1F2-3F559AD8501AQ37722781-CA6CD280-1DEA-4B93-8E4E-8E3843FCF14FQ38670983-40D276F5-22C2-4F9A-8E89-6522860C6969Q38866988-A5331455-2C64-4D1B-AFFE-8C6A0FC4970AQ39150092-CA11F226-2B24-4E1D-98C2-A1588C2356E5Q47105597-1FA478FF-EFD9-4E97-8381-35C6103A7D51Q47133621-F9F3A85B-38D5-44B8-A2F4-8E7D6A840C77Q47244918-58B49A6A-2775-4DB9-BF0F-E5318BA13499Q47420416-765315F6-AB4F-4C26-A832-17B2D9123982Q48505652-7573C77D-6029-4E79-8CD4-C4D9C299B057Q49792274-5C6B3336-F928-4B0A-A912-B29089E9E2A2Q52658935-353BF9D1-BBB6-4543-876D-0FA0BD5EA4D0Q54795534-375EB05F-7F94-4EC8-9AC1-E18003B885FFQ58554016-DB7FD80D-450A-4CFA-95B0-22F303179E2A
P2860
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.
@ast
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.
@en
type
label
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.
@ast
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.
@en
prefLabel
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.
@ast
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.
@en
P2860
P50
P1433
P1476
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.
@en
P2093
Dorotea Crialesi
Luana Lionetto
P2860
P2888
P356
10.1186/S40064-015-1636-9
P577
2015-12-30T00:00:00Z
P5875
P6179
1043681923